Elsevier

Brain, Behavior, and Immunity

Volume 44, February 2015, Pages 100-105
Brain, Behavior, and Immunity

Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders

https://doi.org/10.1016/j.bbi.2014.09.001Get rights and content

Abstract

Animal models indicate that maternal infection during pregnancy can result in behavioral abnormalities and neuropathologies in offspring. We examined the association between maternal inpatient diagnosis with infection during pregnancy and risk of ASD in a Swedish nationwide register-based birth cohort born 1984–2007 with follow-up through 2011. In total, the sample consisted of 2,371,403 persons with 24,414 ASD cases. Infection during pregnancy was defined from ICD codes. In the sample, 903 mothers of ASD cases (3.7%) had an inpatient diagnosis of infection during pregnancy. Logistic regression models adjusted for a number of covariates yielded odds ratios indicating approximately a 30% increase in ASD risk associated with any inpatient diagnosis of infection. Timing of infection did not appear to influence risk in the total Swedish population, since elevated risk of ASD was associated with infection in all trimesters. In a subsample analysis, infections were associated with greater risk of ASD with intellectual disability than for ASD without intellectual disability. The present study adds to the growing body of evidence, encompassing both animal and human studies, that supports possible immune-mediated mechanisms underlying the etiology of ASD.

Introduction

Little is known about the etiology of autism spectrum disorders (ASD), but there is suggestive evidence for the role of environmental exposures during critical periods of early neurodevelopment (Newschaffer et al., 2007). Prenatal infection is a plausible risk factor for ASD, given that the teratogenic effect of prenatal infections such as rubella, cytomegalovirus or Toxoplasma gondii on the central nervous system is well established (Johnson, 1994). Numerous animal studies demonstrate that prenatal or early postnatal infections can result in both acute and persistent neurological and behavioral abnormalities in offspring resembling autistic traits or schizophrenia (Asp et al., 2009, Meyer et al., 2007, Patterson, 2011). However, the validity of such animal models for human ASD is uncertain.

The first studies suggesting an association of prenatal infection with ASD focused on viruses with affinity to the CNS based on the hypothesis of a direct neurotoxic effect. Epidemiological studies of small samples suggested that rubella (Chess et al., 1978, Deykin and MacMahon, 1979), measles, mumps, and influenza (Deykin and MacMahon, 1979) were associated with ASD. More recently, epidemiological studies have expanded infectious exposures to a wide range of viruses and also other pathogens including bacteria. The largest study of over 10,000 ASD cases drawn from Danish electronic health registers reported that maternal hospitalization for viral infection in the first trimester and any infection or bacterial infection in the second trimester were associated with increased ASD risk (Atladottir et al., 2010). However, epidemiological findings have not consistently found evidence of increased ASD risk with infection. For example, a California study of 407 ASD cases reported that hospitalization with infection was associated with increased risk (Zerbo et al., 2013), while a Swedish study of 1216 ASD cases found no such evidence (Buchmayer et al., 2009),

In order to build the evidence base concerning prenatal infection and ASD risk, additional epidemiological studies are necessary. Moreover, as different subtypes of ASD may have different environmental components (Frazier et al., 2014), it is important to examine whether prenatal infection differentially influences ASD subtype risk (with or without intellectual disability). Here, we examined whether maternal hospitalization with infection during pregnancy, type of infection, and timing of infection influences risk of ASD in the largest study to-date. In a subsample of the Swedish population with information on ASD co-morbid with or without intellectual disability, we further examined the associations of prenatal infection with these different subtypes of ASD (Szatmari et al., 2007).

Section snippets

Overview

The Swedish population register system retains routinely collected health and sociodemographic data on the entire population of Sweden. The registers are cross-linked via each person’s unique national registration number assigned to all Swedish residents at birth or upon migration to Sweden (Ludvigsson et al., 2009). The ascertainment of ASD in the total Swedish population is based on data from national registers primarily covering inpatient admissions. In the subsample study of ASD with or

Results

In the total Swedish population, among the 24,414 ASD cases and 2,346,989 non-cases, 903 (3.7%) of ASD cases and 61,642 (2.6%) of non-cases had mothers had a hospitalization with an infection diagnosis during pregnancy. In the SYC subsample, 417 of 9585 ASD cases (4.4%) and 16,352 of 487,408 non-cases (3.4%) had a hospitalization with an infection diagnosis during pregnancy. ASD cases were more likely to be male, first-born, have a lower household income, have mothers with a history of

Discussion

Our study of maternal hospitalization with infection and ASD in a large Swedish cohort yielded four main findings. First, maternal inpatient diagnosis of any infection during pregnancy was associated with an increased risk of ASD in the child; these associations appeared somewhat robust to unmeasured confounding. Second, increased risk was observed for a broad spectrum of infectious agents, including bacterial, viral, and other infections. Third, elevated risk of ASD was observed with infection

Conflict of interest statement

All authors declare that there are no conflicts of interest.

Acknowledgments

The authors would like to thank Henrik Dal, Lena Jorgensen, Michael Lundberg, and Susanne Wicks from the Division of Public Health Epidemiology, Department of Public Health Sciences at the Karolinska Institutet for their work on creating and reviewing the analytic datasets.

This study was funded by Autism Speaks Grant No. 7618 and Swedish Research Council grant 2012-2264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References (38)

  • M.W. Abdallah et al.

    Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders

    World J. Biol. Psychiatry

    (2011)
  • P. Ashwood et al.

    The immune response in autism: a new frontier for autism research

    J. Leukoc. Biol.

    (2006)
  • H.O. Atladottir et al.

    Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders

    J. Autism Dev. Disord.

    (2010)
  • A.S. Brown et al.

    Prenatal infection and schizophrenia: a review of epidemiologic and translational studies

    Am. J. Psychiatry

    (2010)
  • S. Buchmayer et al.

    Can association between preterm birth and autism be explained by maternal or neonatal morbidity?

    Pediatrics

    (2009)
  • S.A. Collier et al.

    Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study

    Birth Defects Res. Part A. Clin. Mol. Teratol.

    (2009)
  • E.Y. Deykin et al.

    Viral exposure and autism

    Am. J. Epidemiol.

    (1979)
  • T.W. Frazier et al.

    A twin study of heritable and shared environmental contributions to autism

    J. Autism Dev. Disord.

    (2014)
  • R. Gedeborg et al.

    Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients

    J. Clin. Epidemiol.

    (2007)
  • Cited by (233)

    • Stress, inflammation, microbiome and depression

      2023, Pharmacology Biochemistry and Behavior
    View all citing articles on Scopus
    View full text